Cabaletta Bio
CABA | NASDAQ
$1.11
-$0.17 (-13.28%)
At close: Nov 16, 2026, 4:00 PM ET
$1.13
+$0.02 (+1.83%)
After-hours:
Nov 16, 2026, 7:43 PM ET
-13.28%
(1D)No price chart data available for 1D timeframe.
Rating
30
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #791/1021 (Top 77%)
Key Statistics
Market Data
Market Cap $239.45M
1D Range
1.10 1.26
52W Range
1.10 4.15
Valuation (TTM)
PE -0.78
PB 0.84
EV/EBITDA 0.20
Valuation (NTM)
Forward PE N/A
Forward PEG 0.02
Price Target $14.00
Cash Flow
FCF Yield -67.9%
SBC Adj. FCF Yield -76.3%
SBC Impact -12.5%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y 18.1% |
-1.1%
FCF 3Y | 5Y -32.3% |
-32.5%
Returns
ROA -56.3%
ROE -106.8%
ROIC -63.0%
Financial Health
Net Cash
$299.38M
Current Ratio 6.55
Interest Coverage -87.26
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Cabaletta Bio, Inc. is a biotechnology firm in the clinical development stage, specializing in the invention and advancement of sophisticated engineered T cell therapies. Its core mission is to treat ...
Sector Healthcare
Industry Biotechnology
Employees 156
IPO Date Oct 25, 2019
Website www.cabalettabio.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
6
Consensus
Buy
Price Target
$14.00
Upside
+1161.26%
Buy (5)
Hold (1)
Sell (0)
Add to Watchlist
Select watchlists to add or remove CABA